Unlock Strategic Intelligence with Fundz
Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.
Colossal Biosciences announced it raised $163 Million in an amended filing from an offering of $174 Million
Colossal Biosciences announced it raised $163 Million in an amended filing from an offering of $174 Million
07/23/24, 6:08 PM
Location
Money raised
$163 million
Industry
biotechnology
🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.
Company Info
Location
austin, texas, united states
Additional Info
Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Track Every New Funding Round — Before Anyone Else
This is just a small preview. Unlock access to thousands more filtered results — updated in real-time by stage, region, investor & more.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.
Related people
EH
BH
BH